The Human Cell Atlas project makes its vast collection of data available through a Data Portal that offers direct export to a Terra workspace.
As we head into the holiday week, we give thanks to one of the Terra teams whose role is as essential as it is often unsung: Frontline Support.
Lead Educator Robert Majovski presents a listicle of 8 key resources that can help Terra newcomers and veterans alike get the most out of the Terra platform.
Samantha Zarate of the Schatz Lab takes us behind the scenes of the large-scale analysis that demonstrated the benefits of the new T2T-CHM13 reference genome for variant calling.
Subscribe to our blog
One of our biggest feature developments so far this year has been the addition of Galaxy, the popular open-source bioinformatics application, to Terra's interactive analysis portfolio.
We are taking the next step in our journey by joining our efforts with Microsoft, a partner that truly needs no introduction. This multi-year partnership will bring together advanced technologies, industry expertise, and scale to accelerate the next generation of the Terra platform for health and life sciences research. [...]
Last week we were very excited for our colleagues in the gnomAD team, who announced on their blog that the entire gnomAD dataset is now available for direct use or download from Google Cloud as well as Amazon Web Services and Microsoft Azure. If you're not familiar with gnomAD, the name stands for Genome Aggregation [...]
Guest blog post by Kylee Degatano, Product Manager for the Lantern Pipelines team in the Data Sciences Platform at the Broad Institute. I'm very excited to announce the recent release of WDL Analysis Research Pipelines (WARP), a brand new, public GitHub repository of cloud-optimized WDL workflows that are used in production at the [...]
We’d love to feature your story
Contact us at info@terra.bio
To see all blog posts, visit our
Archive page
Terra is developed by the Broad Institute of MIT and Harvard
in collaboration with Microsoft and Verily.
Terra is developed by the
Broad Institute of MIT and Harvard in collaboration with Microsoft and
Verily Life Sciences.
